Cytosorbents (CTSO) Gross Margin (2011 - 2026)
Cytosorbents' (CTSO) quarterly Gross Margin came in at 73.18% in Q2 2026, up 232.0% on a YoY basis from 22.04% in Q2 2025, and up 5.81% quarter-over-quarter from 69.16% in Q1 2026.
Powered by 
Analysis
Cytosorbents (CTSO) Gross Margin (2011 - 2026) Analysis & Trends
Cytosorbents (CTSO) has reported Gross Margin for 16 consecutive years, with 73.18% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Gross Margin rose 232.0% year-over-year to 73.18%; the trailing twelve-month figure through Jun 2026 stood at 71.61% (up 367.0% YoY), and the FY2025 full-year result was 71.48%, up 156.0% from the prior year.
- Gross Margin grew to 73.18% in Q2 2026 per CTSO's latest filing, from 69.16% in the prior quarter.
- Across five years, Gross Margin topped out at 76.46% in Q1 2024 and bottomed at 44.6% in Q3 2022.
- Historically, Gross Margin has averaged 66.15% across 5 years, with a median of 68.75% in 2024.
- The sharpest annual moves came in 2022 and 2024: Gross Margin sank 3017 bps in 2022, then jumped 1954 bps in 2024.
- Over 5 years, Gross Margin stood at 61.31% in 2022, then dropped by 0 bps to 61.27% in 2023, then gained by 12 bps to 68.35% in 2024, then advanced by 8 bps to 73.68% in 2025, then fell by 1 bps to 73.18% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 73.18%, 69.16%, and 73.68% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 57.71% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 67.78% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 64.99% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 68.27% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 70.71% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 77.46% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 60.21% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 63.44% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 45.84% |
| 10 | Cytosorbents | 20.00 Mn | 15.59 Mn | 7.05 Mn | 73.18% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 73.18% |
| Mar 31, 2026 | 69.16% |
| Dec 31, 2025 | 73.68% |
| Sep 30, 2025 | 70.28% |
| Jun 30, 2025 | 70.85% |
| Mar 31, 2025 | 71.12% |
| Dec 31, 2024 | 68.35% |
| Sep 30, 2024 | 61.02% |
| Jun 30, 2024 | 73.55% |
| Mar 31, 2024 | 76.46% |
| Dec 31, 2023 | 61.27% |
| Sep 30, 2023 | 63.48% |
| Jun 30, 2023 | 63.47% |
| Mar 31, 2023 | 56.92% |
| Dec 31, 2022 | 61.31% |
| Sep 30, 2022 | 44.60% |
| Jun 30, 2022 | 58.21% |
| Mar 31, 2022 | 73.79% |
| Dec 31, 2021 | 71.04% |
| Sep 30, 2021 | 74.77% |